Abstract
Primary hyperparathyroidism is the commonest cause of hypercalcemia in the ambulatory setting. Widespread use of routine laboratory screening has resulted in a large number of patients presenting with subclinical disease. In truly asymptomatic patients, consensus guidelines have been developed to determine which patients need definitive treatment. The most common pathologic finding is parathyroid adenoma, followed by hyperplasia, double adenomas and parathyroid carcinoma. The mainstay of treatment is surgery. While there is still an important role for four gland exploration and evaluation, there is now considerable interest in a more focused surgical approach. This paradigm shift is based on localizing studies that combine sestamibi scanning with anatomic imaging, most commonly ultrasound scanning. A range of minimally invasive approaches have been developed to treat parathyroid adenomas, including unilateral and single gland explorations as well as a number of different endoscopic techniques. Intra-operative rapid parathormone assay has replaced histologic examination as a more effective method to confirm the adequacy of surgery in most cases. Functional localization and exploration using a gamma probe has also been described. The management of patients with persistent or recurrent hyperparathyroidism is difficult and requires a multidisciplinary approach.
Similar content being viewed by others
References
Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med. 2004;350:1746–1751.
McHenry CR. What’s new in general surgery: endocrine surgery. J Am Coll Surg. 2002; 195: 364–371.
Pasieka JL. What’s new in general surgery: endocrine surgery. J Am Coll Surg. 2004;199:437–445.
Hunt PS, Poole M, Reeve TS. A reappraisal of the surgical anatomy of the thyroid and parathyroid glands. Br J Surg. 1968; 55:63–66.
Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95: 14–21.
Shaha AR. Parathyroid re-exploration. Otolaryngol Clin North Am. 2004;37: 833–843, x.
Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2:494–503.
Bilezikian JP, Potts Jr. JT, Fuleihan Gel H et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353–5361.
Coakley AJ, Kettle AG, Wells CP et al 99 Tcm sestamibi — a new agent for parathyroid imaging. Nucl Med Commun. 1989; 10: 791–794.
Shaha AR. Localization studies for hyperparathyroidism: implications for surgery. Acta Otorhinolaryngol Belg 2001;55:139–145.
Buck AK, Nekolla S, Ziegler S et al. Spect/Ct. J Nucl Med. 2008; 49: 1305–1319.
Friedman K, Somervell H, Patel P et al. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery. 2004; 136:1199–1204.
McHenry CR, Lee K, Saadey J et al. Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg. 1996; 183:25–30.
Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35:266–276.
Carling T, Udelsman R. Focused approach to parathyroidectomy. World J Surg. 2008;32:1512–1517.
Shaha AR, Patel SG, Singh B. Minimally invasive parathyroidectomy: the role of radio-guided surgery. Laryngoscope. 2002;112:2166–2169.
Udelsman R, Donovan PI, Sokoll LJ. One hundred consecutive minimally invasive parathyroid explorations. Ann Surg. 2000;232:331–339.
Ruda JM, Hollenbeak CS, Stack Jr BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132:359–372.
Ikeda Y, Takami H, Niimi M et al. Endoscopic thyroidectomy and parathyroidectomy by the axillary approach. A preliminary report. Surg Endosc. 2002;16:92–95.
Terris DJ, Stack Jr. BC, Gourin CG. Contemporary parathyroidectomy: exploiting technology. Am J Otolaryngol. 2007;28:408–414.
Miccoli P, Berti P, Materazzi G et al. Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial. Surg Endosc. 2008;22:398–400.
Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126:1023–1028; discussion 1028–1029.
Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86: 378–380.
Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–544.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gopalakrishna Iyer, N., Shaha, A.R. Current concepts in the management of primary hyperparathyroidism. Indian J Surg Oncol 1, 112–119 (2010). https://doi.org/10.1007/s13193-010-0023-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-010-0023-9